Invention Grant
- Patent Title: Recombinant lectin and uses thereof
-
Application No.: US17394313Application Date: 2021-08-04
-
Publication No.: US11767351B2Publication Date: 2023-09-26
- Inventor: Markus Kalkum , Yoko Fujita-Yamaguchi , Karine Bagramyan , Teresa B. Hong , Sarah Shuck
- Applicant: CITY OF HOPE
- Applicant Address: US CA Duarte
- Assignee: CITY OF HOPE
- Current Assignee: CITY OF HOPE
- Current Assignee Address: US CA Duarte
- Agency: Perkins Coie LLP
- Agent Lara J. Dueppen; Allison M. Glasunow
- The original application number of the division: US16165725 2018.10.19
- Main IPC: G01N33/574
- IPC: G01N33/574 ; C07K14/36 ; G01N33/58 ; A61K51/08

Abstract:
Disclosed herein are a recombinant Streptomyces S27S5 hemagglutinin (SHA), and homologues thereof, and a fusion protein of a fluorescent protein (such as GFP and mCherry1) and SHA or a homologue thereof, which specifically bind to carbohydrates, including oligomeric sugars that terminate in L-rhamnose or D-galactose. The SHA, SHA homologues, and fusion proteins can be used to detect a variety of microorganisms or cancer or tumor antigens.
Public/Granted literature
- US20210395315A1 RECOMBINANT LECTIN AND USES THEREOF Public/Granted day:2021-12-23
Information query
IPC分类: